GLOW

Also known as: GLOW blend, GLOW peptide

Limited evidence
ClassSkin and recovery blend: GHK-Cu + BPC-157 + TB-500
Research statusComponents studied separately; blend not studied
TypePre-mixed blend
Components3
Independent testingComing soon

GLOW explainer video

GLOW and KLOW: The Peptide Blends, Explained

The skin, glow and recovery blends: what GHK-Cu, BPC-157, TB-500 and KPV each bring to the mix.

Under a minute. Education only, not medical advice.

What's in the blend

Overview

GLOW is a pre-mixed blend of three research peptides: GHK-Cu, BPC-157 and TB-500. It has taken off in skin, beauty and women's wellness circles, where it is talked about for radiance, firmness and faster bounce-back.

The star ingredient is GHK-Cu, a small copper-binding peptide your body already makes. It is found in human plasma, saliva and urine, and its levels fall with age. In lab and skin studies GHK-Cu has been linked to collagen production, wound repair and antioxidant activity, which is why it shows up in serums and skin care. In the GLOW blends sellers list, GHK-Cu makes up most of the blend by weight, with BPC-157 and TB-500 added for their repair reputation.

What the research says: each ingredient has been studied on its own, mostly in cells and animals, plus small studies of GHK-Cu applied to skin. Reviews by Pickart and colleagues summarize GHK-Cu's effects on skin remodeling and on the activity of genes tied to repair. GLOW as a blend has not been studied in a published trial, so its reputation rests on its parts.

Status check: GLOW is not an approved medicine. Topical GHK-Cu is a familiar cosmetic ingredient, but injectable GHK-Cu, BPC-157 and TB-500 are not FDA-approved, and FDA's compounding safety page lists them as nominated but withdrawn from Category 2. BPC-157 and TB-500 are also prohibited in sport by WADA. Talk with a clinician or dermatologist before trying anything new.

Independent testing: coming soon

We have not tested GLOW products yet, so there are no Institute lab results, company rankings or Index Scores on this page. When we do, they will appear here.

Sources

  1. Peptide America. GLOW and KLOW Peptide Blends: What Is in Them (reviewed September 2026). peptideamerica.org
  2. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987.
  3. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108.
  4. Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal. 2025;21(4):485-495.
  5. Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy. 2012;12(1):37-51.
  6. U.S. FDA. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (content current as of April 22, 2026). fda.gov
  7. World Anti-Doping Agency. The 2026 Prohibited List (sections S0 and S2), in force January 1, 2026. wada-ama.org

The Peptide Institute Weekly

Research. Testing. Regulation. No hype.

One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.

  • New research, summarized in plain English
  • Independent lab results as they publish
  • Score and ranking movements